Profiles: Page 4

The latest opinion pieces by industry thought leaders

  • A portrait of Nello Mainolfi framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nello Mainolfi
    Image attribution tooltip

    Entrepreneurs: Nello Mainolfi

    Kymera Therapeutics’ CEO is chasing untreated disease targets by advancing a game-changing technology.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Nekzad Shroff framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nekzad Shroff
    Image attribution tooltip

    Tech Wizards: Nekzad Shroff

    Considered one of the industry’s ‘most powerful minds,’ the VP of product management at Saama is developing digital solutions with impact.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Nancy Lurker framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nancy Lurker
    Image attribution tooltip

    Legacy Leaders: Nancy Lurker

    The CEO of EyePoint Pharmaceuticals is positioning the company to fundamentally reshape how retinal diseases are treated.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Mike Gladstone framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Mike Gladstone
    Image attribution tooltip

    Legacy Leaders: Mike Gladstone

    The global president of Pfizer's Inflammation and Immunology unit is unlocking his team’s potential to meet big goals against a promising pipeline.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Maureen Hennessey framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Maureen Hennessey
    Image attribution tooltip

    DE&I Champions: Maureen Hennessey

    The senior vice president, director of value transformation at PRECISIONvalue is moving the needle on patient nonadherence challenges.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Matt Walz framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Matt Walz
    Image attribution tooltip

    Tech Wizards: Matt Walz

    The innovative CEO is driving global clinical trial enrollment with a novel approach for the industry.   

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Matt Clark framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Matt Clark
    Image attribution tooltip

    Tech Wizards: Matt Clark

    X-Chem’s CEO has pioneered DNA-encoded libraries to revolutionize small molecule discovery.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Mary-Ann Etiebet framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Mary-Ann Etiebet
    Image attribution tooltip

    DE&I Champions: Dr. Mary-Ann Etiebet

    Merck’s associate vice president of health equity is making DE&I a part of the pharma giant's day-to-day strategy.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Mark Sullivan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Mark Sullivan
    Image attribution tooltip

    DE&I Champions: Mark Sullivan

    Medicines Development for Global Health’s founder is committed to eliminating neglected tropical diseases around the world.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Mark Goldberg framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Mark Goldberg
    Image attribution tooltip

    Legacy Leaders: Dr. Mark Goldberg

    The savvy clinical trials pro has built a global CRO by targeting the needs of the industry’s bustling biotech sector.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Lori Abrams framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Lori Abrams
    Image attribution tooltip

    DE&I Champions: Lori Abrams

    The VP of patient advocacy and clinical research diversity at WCG is shaking up the trial space by shining a light on underserved populations.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Lisa Walters-Hoffert framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Lisa Walters-Hoffert
    Image attribution tooltip

    Entrepreneurs: Lisa Walters-Hoffert

    Daré Bioscience’s CFO and co-founder is determined to rapidly advance innovations in women’s health.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Laxmi Bonagiri framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Laxmi Bonagiri
    Image attribution tooltip

    DE&I Champions: Laxmi Bonagiri

    EClinical Solutions’ VP of India operations is creating a path to increase the number of women in senior leadership roles while changing the course of diseases for millions.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Laurent Levy framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Laurent Levy
    Image attribution tooltip

    Disrupters: Laurent Levy

    Nanobiotix’s co-founder is applying the principles of nanophysics to fight cancer with a universal mechanism of action.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Laura Niklason framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Laura Niklason
    Image attribution tooltip

    Entrepreneurs: Dr. Laura Niklason

    The founder, president and CEO of Humacyte is turning science fiction into regenerative medicine reality.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of LaQuinta Jernigan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by LaQuinta Jernigan
    Image attribution tooltip

    DE&I Champions: LaQuinta Jernigan

    The chief operating officer and ‘face’ of mdgroup is a leading voice in the efforts to diversify clinical trials.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Kunal Ghosh framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kunal Ghosh
    Image attribution tooltip

    Tech Wizards: Kunal Ghosh

    The leader of Inscopix embodies a 'bootstrap' approach to entrepreneurship, from soldering early versions of the Inscopix technology to taking a 'science-first' approach to fundraising.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Kuldeep Singh Rajput framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kuldeep Singh Rajput
    Image attribution tooltip

    Entrepreneurs: Kuldeep Singh Rajput

    Bringing digital solutions to Big Pharmas adapting to a more patient-centric age, the CEO and founder of Biofourmis has instituted a flexible approach that keeps its tech on the leading edge.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Kim Johnson framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kim Johnson
    Image attribution tooltip

    Legacy Leaders: Kim Johnson

    The Global CEO is breathing fresh air into Ogilvy Health as she blazes a new trail at the storied agency.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Dr. Kerry Blanchard framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Everest Medicines
    Image attribution tooltip

    Legacy Leaders: Dr. Kerry Blanchard

    The former CEO of Everest Medicines has focused on breaking new ground for China-based innovation.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Kathy Lee-Sepsick framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kathy Lee-Sepsick
    Image attribution tooltip

    Entrepreneurs: Kathy Lee-Sepsick

    Kathy Lee-Sepsick, the founder of Femasys, is determined to change the game in long-neglected areas of women’s healthcare, some of which haven’t had much innovation in more than a century.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Karin Jooss framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Karin Jooss
    Image attribution tooltip

    Innovators: Karin Jooss

    The EVP and head of R&D at Gritstone bio is using her decades as a visionary drug developer to help the company advance vaccines for cancer.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Julie Kim framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Julie Kim
    Image attribution tooltip

    Disrupters: Julie Kim

    The president of Takeda’s U.S. business unit and U.S. country head has steered through the pandemic, turning her aptitude for bringing people together into a master class in perseverance.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Dr. Jordan Schecter framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Jordan Schecter
    Image attribution tooltip

    Innovators: Dr. Jordan Schecter

    The VP of cellular therapy at Janssen has used collaboration, creative thinking and pragmatism to create a CAR-T multiple myeloma breakthrough.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Jonathan Steckbeck framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jonathan Steckbeck
    Image attribution tooltip

    Disrupters: Jonathan Steckbeck

    The CEO, founder and president of Peptilogics is changing the game for the peptide medicine space with a promising pipeline and a disruptive discovery platform.

    Meagan Parrish • Sept. 6, 2022